GYRE THERAPEUTICS, INC. (GYRE) — Total Assets

Annual figures by fiscal year, from SEC filings.

2010: $262.79M2011: $258.13M2012: $189.58M2013: $145.87M2014: $2.98M2015: $69.52M2016: $38.09M2017: $39.51M2018: $124.92M2019: $98.55M2020: $94.85M2021: $55.66M2022: $84.75M2023: $116.54M2024: $125.41M2025: $166.13M$166.13M
2010Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$166.13M+32.5%
2024$125.41M+7.6%
2023$116.54M+37.5%
2022$84.75M+52.3%
2021$55.66M-41.3%
2020$94.85M-3.8%
2019$98.55M-21.1%
2018$124.92M+216.1%
2017$39.51M+3.7%
2016$38.09M-45.2%
2015$69.52M+2232.1%
2014$2.98M-98.0%
2013$145.87M-23.1%
2012$189.58M-26.6%
2011$258.13M-1.8%
2010$262.79M